R-Biopharm AG: Flu tests from R-Biopharm also detect new virus variants
25.11.2022 11:23:27 CET | news aktuell GmbH | Press release
Darmstadt, November 25, 2022: The flu season has begun and different virus variants are also circulating in Germany. With the flu tests from biotechnology company R-Biopharm, patients quickly have certainty: Its RIDA®GENE Flu assays also reliably detect the two novel variants. The company made the announcement with regard to influenza A H1N1pdm09, which is circulating primarily in the United Kingdom, and the H3N2 subtype, which was rampant in Denmark in the spring and is currently dominating influenza activity in Germany.
"Mutations in the target gene (MP gene) can affect the diagnostic performance of influenza screening assays, producing false-negative test results," explains Dr. Andreas Simons, Head of Product Management at R-Biopharm. " Alignments of the detection systems we used with the described sequences of the two novel virus variants showed no mismatches. Their reliable detection is not affected by the described mutations."
This means laboratories can continue to reliably confirm or rule out influenza infections using R-Biopharm's RIDA®GENE (PG0505, PG0545, PG6825) assays. The tests are multiplex real-time RT-PCR for the direct qualitative detection of influenza viruses.
About R-Biopharm
R-Biopharm AG, located in Darmstadt, is one of Germany's leading biotechnology companies. Founded in 1988, the company is family-run in the second generation and considers itself as a pioneer for health and quality of life. Its aspiration: to provide the highest possible precision, safety, clarity and certainty in prevention, therapy and healing. To this end, R-Biopharm develops technologies, products and solutions for Clinical Diagnostics, Nutrition Care and Food and Feed Analytics – and does so in internationally recognized top quality. R-Biopharm is the world market leader for test systems in the field of allergen analysis.
R-Biopharm unites research, development and sales under one roof in order to respond to ever new challenges with agile processes and to accompany the steadily growing world population into a new health era. The company is represented in more than 120 countries – through 29 subsidiaries and 120 distributors. It employs around 1,400 people worldwide (690 at its headquarters in Darmstadt) and was repeatedly recognized with the "Sustainability Award" for sustainable and profitable growth.
Press contact:
Simone Feiler
Head of Corporate Brand Communication
https://r-biopharm.com/de/kontakt/presse
https://r-biopharm.com/de/news-presse/download-galerie
R-Biopharm AG
An der neuen Bergstraße 17
64297 Darmstadt
Phone: 0 61 51 - 81 02-538
Mobile: 0 160 - 55 273 60
Fax: 0 61 51 - 81 02-40
Email: s.feiler@r-biopharm.de
Images
About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
HEIDELBERG systematically pressing ahead with strategic development – solid start to FY 2026/202719.8.2026 09:02:17 CEST | Press release
Taking over manroland sheetfed lifecycle business and POLAR production operations strengthens core business ONBERG pursuing partnership with Skyeton in European defense sector Move into production of sodium-ion battery storage systems taps into new potential First-quarter incoming orders lay solid foundation for further business development Sales and EBITDA margin at start of year in line with expectations Forecast for financial year 2026/2027 confirmed
Polarise secures further debt financing to expand its European AI cloud platform18.8.2026 11:47:20 CEST | Press release
Düsseldorf, 18. August 2026 – Polarise Holding GmbH (“Polarise”), a European provider of sovereign AI cloud solutions, has secured a debt financing partnership with SWI Stoneweg Icona Group (“SWI Group”) to accelerate the expansion of its European AI cloud platform. The financing of up to a high double-digit million-euro amount strengthens Polarise’s funding base for the continued execution of its growth strategy. As part of the new financing structure, Polarise and SWI Group have agreed to transition the previously announced majority equity investment agreement into a debt financing arrangement. Michel Boutouil, CEO of Polarise, said: “Our growth strategy is aimed at building Europe’s AI infrastructure of the future – with sustainable, highly efficient AI Factories and sovereign AI compute for businesses. We are executing this strategy with significant momentum and strong partners. Polarise develops and operates AI data centres – so-called AI Factories – in Germany and across Europe.
Central Council calls for prevention through education and awareness-raising3.8.2026 09:19:17 CEST | Press release
Commemorative event to mark the European Holocaust Remembrance Day for Sinti and Roma on 2 August 2026 in Auschwitz-Birkenau
CHRIST chooses fulfillmenttools and commercetools for a future-proof commerce architecture31.7.2026 12:47:56 CEST | Press release
Cologne – CHRIST Juweliere und Uhrmacher, one of Europe's most renowned jewelry retailers, is partnering with fulfillmenttools to transform the way it manages and orchestrates orders across its retail network. CHRIST is implementing the Agentic Order Management System (OMS) – as part of a broader transformation in which the retailer is building a modular, future-proof commerce architecture powered by commercetools Sphere, the autonomous commerce platform. The new system landscape spans stores and digital channels across Germany, Austria and the Netherlands. Breaking free from monolithic constraints For internationally operating retailers, the ability to respond flexibly and quickly to customer demand is a key success factor. This is especially true in the jewellery trade, which is shaped by specific requirements: high-value products, complex inventory structures, and customers who expect a first-class, seamless shopping experience at every touchpoint. CHRIST has built a strong operatio
Bikeleasing Group announces strategic investment in New Zealand’s leading bike leasing company Workride / Next strategic step in cross-continental expansion29.7.2026 14:18:02 CEST | Press release
The Bikeleasing Group announces strategic investment in Workride, New Zealand’s market leader for company bike leasing as an employee benefit. Around 2,000 New Zealand employers already use Workride’s offering. The investment extends the Bikeleasing Group’s international presence and marks its next cross-continental step in its growth trajectory.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom